Article Information
PubMed
Print ISSN
Online ISSN
History
- Received January 18, 2010
- Accepted May 17, 2010
- Published online July 15, 2010.
Article Versions
- Earlier version (May 17, 2010 - 06:45).
- Earlier version (May 24, 2010 - 07:37).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Aishen Gong,
- Xiaoyan Chen,
- Pan Deng and
- Dafang Zhong
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (A.G., X.C., P.D., D.Z.); and Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, China (A.G.)
- Address correspondence to:
Dafang Zhong, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 646 Songtao Road, Shanghai 201203, China. E-mail: dfzhong{at}mail.shcnc.ac.cn
Statistics from Altmetric.com
Article usage
In this issue
Metabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia Patients
